# Cook IVC Filter Study

Study · id `cardio:ct-nct02046096` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02046096](<https://clinicaltrials.gov/study/NCT02046096>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02046096

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 473 participants.

## Technical summary

Registry record NCT02046096. Non-randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2018-12-18 (actual). Results posted on 2022-01-11.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 473 participants (enrolled count; ClinicalTrials.gov record NCT02046096, source copy `cardio:ctgov-nct02046096-2022-01-20`, retrieved 2026-10-31)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT02046096, source copy `cardio:ctgov-nct02046096-2022-01-20`, retrieved 2026-10-31)
- Primary completion: 2018-12-18 (actual) (ClinicalTrials.gov record NCT02046096, source copy `cardio:ctgov-nct02046096-2022-01-20`, retrieved 2026-10-31)
- Completion: 2019-08-09 (actual) (ClinicalTrials.gov record NCT02046096, source copy `cardio:ctgov-nct02046096-2022-01-20`, retrieved 2026-10-31)
- Results first posted: 2022-01-11 (ClinicalTrials.gov record NCT02046096, source copy `cardio:ctgov-nct02046096-2022-01-20`, retrieved 2026-10-31)
- Countries: United States; Australia; United Kingdom (ClinicalTrials.gov record NCT02046096, source copy `cardio:ctgov-nct02046096-2022-01-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02046096-2022-01-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Cook IVC Filter Study
- Acronym: CIVC
- Condition: Pulmonary Embolism
- Intervention (Device): Günther Tulip® Vena Cava Filter
- Intervention (Device): Cook Celect® Vena Cava Filters
- Lead sponsor: Cook Research Incorporated
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Cook Research Incorporated (`cardio:org-cook-research-incorporated`)

## Provenance

Content hash: 9565c3f69e0d4870b7418aa7125c96f5a7405b6cd1e2b2f141351b1d7886e5c4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
